Correlation Between Mereo BioPharma and Day One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Mereo BioPharma and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Day One.

Diversification Opportunities for Mereo BioPharma and Day One

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Mereo and Day is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Day One go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Day One

Given the investment horizon of 90 days Mereo BioPharma Group is expected to generate 0.83 times more return on investment than Day One. However, Mereo BioPharma Group is 1.2 times less risky than Day One. It trades about -0.18 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest  373.00  in Mereo BioPharma Group on December 27, 2024 and sell it today you would lose (131.37) from holding Mereo BioPharma Group or give up 35.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Mereo BioPharma Group  vs.  Day One Biopharmaceuticals

 Performance 
       Timeline  
Mereo BioPharma Group 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Day One Biopharmaceu 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Mereo BioPharma and Day One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo BioPharma and Day One

The main advantage of trading using opposite Mereo BioPharma and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.
The idea behind Mereo BioPharma Group and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk